Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2025-12-24 @ 10:48 PM
NCT ID:
NCT00271869
Eligibility Criteria:
Inclusion Criteria:
* Presence of at least one diagnostic clinical sign of chronic GVHD or an appropriate constellation of distinctive signs confirmed by biopsy or other relevant diagnostic tests
* Presence of liver or lung manifestations of chronic GVHD
* Indication for systemic immunosuppressive therapy defined according to NIH consensus
* No prior immunosuppressive therapy for chronic GVHD of the liver or lungs
* Adequate renal, hepatic, pulmonary and cardiac function
* Karnofsky performance score \>- 50%
* Women of childbearing potential must agree to use a reliable method of birth control for the duration of the study
* Signed written informed consent
Exclusion Criteria:
\-
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00271869
Study Brief:
Protocol Section:
NCT00271869